Languages SpokenEnglish Common ConditionsBased on the training and education, Dr. Daniel Thomas, MD may treat patients with the following conditions. Please always check with Dr. Daniel Thomas, MD directly about which exact conditions he treats. - Forehead Wrinkles
- Bulbous Nose
- Loose Facial Skin
- Facial Volume Loss
- Overweight & Obesity
- Droopy Eyelids
- Large Breasts
- Excessive Sweating
- Dark Circles Under Eyes
- Loose Body Skin
- Crooked Nose
- Stretched Ears
- Neck Bands
- Sparse Eyelashes
- Resting Bitch Face
- Unwanted Tattoos
- Flabby Arms
- Small Penis
- Smile Lines
- Prominent Ears
Prescribed MedicationsHydrocodone-Acetaminophen (Generic Name: hydrocodone/acetaminophen) Hydrocodone-Ibuprofen (Generic Name: hydrocodone/ibuprofen) Promethazine Valacyclovir Doxycycline Hyclate Scopolamine TreatmentsBased on the training and education, Dr. Daniel Thomas, MD may perform the following treatments. Please always check with Dr. Daniel Thomas, MD directly about which exact treatments he offers. - Facelift
- Revision Rhinoplasty
- SMAS Facelift
- Body Jet
- Lower Facelift
- Rhinoplasty
- Septoplasty
- Sinus Surgery
- Nose Surgery
Research & PublicationsApproximately 100% of Plastic Surgeons in Chico, CA have available research publications Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib Sensitivity. Chloe Al Thompson-Peach, Daniel Thomas, Mara Dottore, Kelly Lim, Frank Stomski, Romana Panagopoulos, Johannes Foßelteder, Andreas Reinisch, Vashe Chandrakanthan, Sandra Jenkner, Luke Bland, Sharon Paton, Stan Gronthos, Timothy Hercus, Hannah Wardill, Winnie L Kan, Maha Kamel, Paul A Moretti, Stuart M Pitson, Kate Burbury, David Morrall Ross, Pramod Nair, Angel F Lopez, Denis Tvorogov Blood 2026-01-02 RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm. Chung Hoow Kok, Aref Al-Kali, Daniel Thomas, Rong He, Monika M Kutyna, Hassan Alkhateeb, Kelly Lim, Antoine N Saliba, Carla Toop, Aasiya Matin, Hamish Scott, Naseema Gangat, Anna Brown, Abhishek Mangaonkar, Christopher N Hahn, Kebede Begna, Kevin Hung, Patricia Greipp, William J Hogan, Mrinal Patnaik, Mithun Shah, Devendra K Hiwase Blood advances 2025-08-12 Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations. Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, Monika M Kutyna, Aref Al-Kali, Carla Toop, Patricia Greipp, Anna Brown, Syed Shah, Shreyas Khanna, Dariusz Ladon, Vedavyas Gannamani, Dong Chen, Kebede Begna, Zoe K Price, Danielle Rud, Mark R Litzow, William J Hogan, Peter Bardy, Talha Badar, Sharad Kumar, David T Yeung, Mrinal M Patnaik, James M Foran, Rong He, Naseema Gangat, Hamish S Scott, Cecilia Y Arana Yi, Hassan Alkhateeb, Abhishek A Mangaonkar, Daniel Thomas, Christopher N Hahn, Attilio Orazi, Daniel A Arber, Chung Hoow Kok, Ayalew Tefferi, Devendra Hiwase Blood advances 2025-07-08 Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort. Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, Gauri Wechalekar, Aref Al-Kali, Carla R Toop, Patricia Greipp, Monika M Kutyna, Aasiya Matin, Dariusz Ladon, Antoine Saliba, Dong Chen, Kebede Begna, Anna Brown, Danielle Rud, Mark R Litzow, William J Hogan, Peter Bardy, Talha Badar, Sharad Kumar, David T Yeung, Mrinal M Patnaik, James M Foran, Rong He, Naseema Gangat, Mehrdad Hefazi, Hamish S Scott, Cecilia Y Arana Yi, Hassan Alkhateeb, Abhishek A Mangaonkar, Daniel Thomas, Christopher N Hahn, Attilio Orazi, Daniel A Arber, Chung Hoow Kok, Ayalew Tefferi, Devendra Hiwase Blood cancer journal 2025-05-07 Methylation Mesa define functional regulatory elements for targeted gene activation. Y V Liu, J Suryatenggara, H Wong, M K Jayasinghe, J P Tang, H K Tan, J Kwon, Q Zhou, S Ummarino, A K Ebralidze, M T N Le, J G Doench, L Chai, T Benoukraf, D Hiwase, D Thomas, A Di Ruscio, D G Tenen, M A Bassal Research square 2024-10-16 CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting. Kelly Lim, Winnie L Kan, Pramod C Nair, Monika Kutyna, Angel F Lopez, Timothy Hercus, David M Ross, Steven Lane, Chun Yew Fong, Anna Brown, Agnes Yong, David Yeung, Timothy Hughes, Devendra Hiwase, Daniel Thomas PloS one 2024-09-19 Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features. Mihir D Wechalekar, Lin-Pierre Zhao, Monika M Kutyna, Lih En Hong, Joule Li, Kevin Hung, Hamish S Scott, Anna Brown, Christopher C Hahn, Karin Kassahn, Dariusz Ladon, David T Yeung, Daniel Thomas, Mrinal Patnaik, Susanna Proudman, Lionel Ades, Mithun V Shah, Chung H Kok, Devendra K Hiwase Blood cancer journal 2024-07-19 IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation. Lih En Hong, Mihir D Wechalekar, Monika Kutyna, Annabelle Small, Kelly Lim, Chloe Thompson-Peach, Joule J Li, Rakchha Chhetri, Hamish S Scott, Anna Brown, Christopher N Hahn, David T Yeung, Salvia Sajid, Nirmal Robinson, Ranjeny Thomas, Susan Branford, Richard J D'Andrea, Saumya E Samaraweera, Mrinal Patnaik, Susanna Proudman, Daniel Thomas, Chung Hoow Kok, Mithun V Shah, Devendra K Hiwase Blood 2024-05-02 Mitochondrial translocation of TFEB regulates complex I and inflammation. Chiara Calabrese, Hendrik Nolte, Melissa R Pitman, Raja Ganesan, Philipp Lampe, Raymond Laboy, Roberto Ripa, Julia Fischer, Ruhi Polara, Sameer Kumar Panda, Sandhya Chipurupalli, Saray Gutierrez, Daniel Thomas, Stuart M Pitson, Adam Antebi, Nirmal Robinson EMBO reports 2024-01-23 IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation. Niklas Landberg, Thomas Köhnke, Yang Feng, Yusuke Nakauchi, Amy C Fan, Miles H Linde, Daiki Karigane, Kelly Lim, Rahul Sinha, Luca Malcovati, Daniel Thomas, Ravindra Majeti Blood cancer discovery 2023-12-13 Payments From Medical Companies(These can include payments from pharmaceutical companies, medical device companies, and other companies.) Dr. Daniel Thomas, MD has received over $8,993 in payments from medical companies (about the same as the average Plastic Surgeon in Chico, CA) - Over $8,168 in payments for Compensation for services other than consulting, including serving as faculty or as a speaker at a v (92% more than the average Plastic Surgeon in Chico, CA)
- Over $824 in payments for Food and Beverage (19% less than the average Plastic Surgeon in Chico, CA)
ABBVIE INC. - $286.82 payment for Compensation for services other than consulting, including serving as faculty or as a speaker at a v on 12/09/2024 ABBVIE INC. - $5.65 payment for Food and Beverage on 11/20/2024 ABBVIE INC. - $210.20 payment for Compensation for services other than consulting, including serving as faculty or as a speaker at a v on 11/08/2024 ABBVIE INC. - $19.47 payment for Food and Beverage on 10/23/2024 ABBVIE INC. - $123.50 payment for Compensation for services other than consulting, including serving as faculty or as a speaker at a v on 10/04/2024 ABBVIE INC. - $6.05 payment for Food and Beverage on 10/03/2024 ABBVIE INC. - $18.59 payment for Food and Beverage on 08/29/2024 ABBVIE INC. - $8.15 payment for Food and Beverage on 08/19/2024 ABBVIE INC. - $2.30 payment for Food and Beverage on 08/19/2024 ABBVIE INC. - $250.40 payment for Compensation for services other than consulting, including serving as faculty or as a speaker at a v on 08/07/2024 Overview of What Patients Across the Web Are SayingDr. Thomas is consistently praised for the care patients experience, while accounts of his surgical outcomes are sharply divided. Favorable feedback centers on his clear explanations, his patience with questions, and the reassurance he offers before surgery, and the kindness and attentiveness of his staff stand out as a memorable part of the visit. Some praise also points to results that have held up over time and to a lasting sense of being well looked after. Other feedback is openly critical. One allegation describes sagging, displacement, and lingering discomfort following a mini lift, and concerns have been raised that an augmentation and lift fell short of what the patient hoped for, with the cost and difficulty of revision work noted as a further burden. A separate complaint faults a rushed procedure for not being followed by a direct return visit with the surgeon. Criticism of the office itself focuses on a front-desk manner described as rude, along with scheduling and follow-up problems such as canceled appointments. The overall impression is of a practice whose clinical reputation and warm staff inspire strong loyalty, yet whose surgical results and follow-up arrangements have left some patients deeply dissatisfied.
|